LAWYER
LOCATIONS
CULTURE
PRO BONO
DIVERSITY
ALUMNI
CAREERS
繁體
简体
English
Home
/
News & Insights
/
The Potential Impact of the FDA’s Issuance of a “Complete Response Letter” on Publicly-Traded Life Sciences Companies
The Potential Impact of the FDA’s Issuance of a “Complete Response Letter” on Publicly-Traded Life Sciences Companies
November 01, 2008
Read more.
Related Professionals
Search By:
Select Location
New York
Partner
David A. Kotler
New York
+1 212 698 3669
VISIT BIO
Related Services
White Collar, Compliance and Investigations
Life Sciences
Subscribe to Dechert Updates
Subscribe
Related News & Insights
Resources relating to
The Potential Impact of the FDA’s Issuance of a “Complete Response Letter” on Publicly-Traded Life Sciences Companies